COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 108 filers reported holding COHERUS BIOSCIENCES INC in Q2 2017. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,354,924 | -12.4% | 3,036,076 | 0.0% | 0.40% | -0.5% |
| Q2 2023 | $12,964,043 | -37.6% | 3,036,076 | 0.0% | 0.40% | -35.8% |
| Q1 2023 | $20,766,762 | -13.6% | 3,036,076 | 0.0% | 0.62% | -22.9% |
| Q4 2022 | $24,045,720 | -17.6% | 3,036,076 | 0.0% | 0.81% | +38.4% |
| Q3 2022 | $29,177,000 | +28.9% | 3,036,076 | 0.0% | 0.59% | +94.7% |
| Q2 2022 | $22,644,000 | -42.2% | 3,036,076 | 0.0% | 0.30% | -15.2% |
| Q1 2022 | $39,196,000 | -19.1% | 3,036,076 | 0.0% | 0.36% | +33.5% |
| Q4 2021 | $48,456,000 | -0.7% | 3,036,076 | 0.0% | 0.27% | +9.5% |
| Q3 2021 | $48,790,000 | +16.2% | 3,036,076 | 0.0% | 0.24% | +42.9% |
| Q2 2021 | $41,989,000 | -5.3% | 3,036,076 | 0.0% | 0.17% | -23.8% |
| Q1 2021 | $44,357,000 | -15.9% | 3,036,076 | 0.0% | 0.22% | -16.8% |
| Q4 2020 | $52,767,000 | -5.2% | 3,036,076 | 0.0% | 0.27% | -15.7% |
| Q3 2020 | $55,682,000 | +2.7% | 3,036,076 | 0.0% | 0.32% | -3.9% |
| Q2 2020 | $54,224,000 | +10.1% | 3,036,076 | 0.0% | 0.33% | +5.4% |
| Q1 2020 | $49,245,000 | -10.5% | 3,036,076 | -0.6% | 0.31% | +16.7% |
| Q4 2019 | $55,006,000 | -11.1% | 3,055,055 | 0.0% | 0.27% | -22.7% |
| Q3 2019 | $61,895,000 | -8.3% | 3,055,055 | 0.0% | 0.35% | -58.2% |
| Q2 2019 | $67,517,000 | +62.0% | 3,055,055 | 0.0% | 0.83% | +31.2% |
| Q1 2019 | $41,671,000 | +50.7% | 3,055,055 | 0.0% | 0.63% | +25.8% |
| Q4 2018 | $27,648,000 | -45.2% | 3,055,055 | 0.0% | 0.50% | -11.9% |
| Q3 2018 | $50,408,000 | +17.9% | 3,055,055 | 0.0% | 0.57% | +17.5% |
| Q2 2018 | $42,771,000 | +26.7% | 3,055,055 | 0.0% | 0.49% | +18.8% |
| Q1 2018 | $33,758,000 | +25.6% | 3,055,055 | 0.0% | 0.41% | +54.7% |
| Q4 2017 | $26,884,000 | -34.1% | 3,055,055 | 0.0% | 0.26% | -43.7% |
| Q3 2017 | $40,785,000 | -7.0% | 3,055,055 | 0.0% | 0.47% | -5.2% |
| Q2 2017 | $43,840,000 | -32.2% | 3,055,055 | 0.0% | 0.50% | -57.2% |
| Q1 2017 | $64,614,000 | -24.9% | 3,055,055 | 0.0% | 1.16% | -15.5% |
| Q4 2016 | $86,000,000 | +5.1% | 3,055,055 | 0.0% | 1.37% | +35.0% |
| Q3 2016 | $81,814,000 | +58.6% | 3,055,055 | 0.0% | 1.02% | +87.1% |
| Q2 2016 | $51,600,000 | +3.5% | 3,055,055 | 0.0% | 0.54% | -16.6% |
| Q4 2014 | $49,858,000 | – | 3,055,055 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |